GDF15 and hydrops fetalis: An intensive, protocol-driven titration of HF therapy after discharge is currently investigated in the “Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP and GDF-15, of Heart Failure Therapies” (STRONG-HF; NCT03412201) study.